CTSK and metastatic malignant neoplasm in the lymph nodes: There are various explanations for the disagreement with the results reported by Bitu et al. Our findings show that CTSK expressed in either tumor cells or stroma cells correlates with a higher risk for lymph node metastases and a worse DSS.